Effects of Sancai Lianmei Granules in type 2 diabetes patients with metabolic dysfunction-associated fatty liver disease: a randomized prospective open-label controlled trial.

Nutr Metab (Lond) · 2025 · PMC12729198 · PMID 41444638

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, while participants receiving SCLMG in combination with standard treatment demonstrated a reduction in liver fibrosis as assessed by FibroScan compared to those receiving standard treatment alone, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.